New Manufacturing Process Could Improve CAR T Cell Efficacy

Expert said that manufacturing the T cells with a tyrosine kinase inhibitor may allow more patients to get allogeneic stem cell transplant, the current best means of long-term cure.

Related Keywords

Texas , United States , Houston , Chicago , Illinois , Baylor College Of Medicine , American , Maksim Mamonkin , Laquisac Hill , Genentech , Bristol Myers Squibb , American Society Of Clinical Oncology , Baylor College , Gene Therapy , Pharmacy Times , Clinical Oncology , Annual Meeting , Post Transplant Lymphoproliferative Disorder , Peripheralt Cell ,